QL0902, a proposed etanercept biosimilar: pharmacokinetic and immunogenicity profile to its reference product in healthy Chinese male subjects.

Yun Zeng,Jie Huang,Chang Cui,Shuang Yang,Ze-Yu Zhang,Saqib Ali,Zhijun Huang,Guoping Yang

QL0902, a proposed etanercept biosimilar: pharmacokinetic and immunogenicity profile to its reference product in healthy Chinese male subjects.

2020

Yun Zeng
Jie Huang
Chang Cui
Shuang Yang
Ze-Yu Zhang
Saqib Ali
Zhijun Huang
Guoping Yang

ABSTRACTObjectives: To study the pharmacokinetics, safety and immunogenicity of Recombinant Human Tumor Necrosis Factor-α Receptor II: IgG Fc Fusion Protein for Injection (QL0902) and evaluate the ...

Keywords:

Immunogenicity
Biosimilar
Immunology
Etanercept
Pharmacology
Necrosis
Receptor
Medicine
Fusion protein
Recombinant DNA
Pharmacokinetics
reference product

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations